Optimal Dual Time Point for FDG-PET in the Differentiation of Benign from Malignant Lung Lesions: A Simulation Study

Dual time point imaging has been proposed as a means of improving the accuracy of Fluorine-18 fluorodeoxyglucose positron emission tomography (FDG-PET) in the diagnosis of lung malignancy. However, various sampling schedules have been used, which makes direct comparisons between their results difficult. It is unclear whether these schedules have the same accuracy for the diagnosis of lung malignancy, limiting the further development and adoption of these techniques. Although theoretically malignant and benign lesions show increasing difference in FDG uptake with longer uptake periods, the increasing noise due to decay may counteract this advantage and increase variability. In this paper, a method for the design of an optimal dual time point 18F-FDG PET imaging protocol has been proposed to address this issue.

[1]  N. Gupta,et al.  Dynamic positron emission tomography with F-18 fluorodeoxyglucose imaging in differentiation of benign from malignant lung/mediastinal lesions. , 1998, Chest.

[2]  P. Sinha,et al.  Narrow time-window dual-point 18F-FDG PET for the diagnosis of thoracic malignancy , 2003, Nuclear medicine communications.

[3]  D. Feng,et al.  Models for computer simulation studies of input functions for tracer kinetic modeling with positron emission tomography. , 1993, International journal of bio-medical computing.

[4]  Abass Alavi,et al.  Dual time point 18F-FDG PET for the evaluation of pulmonary nodules. , 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[5]  G Lucignani,et al.  Measurement of regional cerebral glucose utilization with fluorine-18-FDG and PET in heterogeneous tissues: theoretical considerations and practical procedure. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[6]  R. Wahl,et al.  Untreated primary lung and breast cancers: correlation between F-18 FDG kinetic rate constants and findings of in vitro studies. , 1998, Radiology.

[7]  Yoshiharu Yonekura,et al.  18F-FDG accumulation with PET for differentiation between benign and malignant lesions in the thorax. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[8]  S. Huang,et al.  The effects of measurement errors in the plasma radioactivity curve on parameter estimation in positron emission tomography. , 1991, Physics in medicine and biology.

[9]  L M Hamberg,et al.  The dose uptake ratio as an index of glucose metabolism: useful parameter or oversimplification? , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[10]  J M Hoffman,et al.  Optimum scanning protocol for FDG-PET evaluation of pulmonary malignancy. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.